Anova

The lack of a unified platform for obtaining sponsorship makes this process protracted and expensive. As a result, the overall clinical trial approach becomes more complicated, which entails inefficient and slow research procedures. Sponsors often don’t have access to package regulations, simplified filing, or approval procedures. The absence of a single system drags on growth because more time is spent matching appropriate sites and people’s profiles. In the end, the system of patient enrollment in research studies is hit hard.

The Anova app accelerates clinical development by bringing sponsors and research organizations together in one place. Anova brings participants in the clinical research process together to speed promising new treatments to market at a reduced cost for a larger number of participants. It kickstarts the development of new treatments through standardization and automation.

Key app functionality

We built a web platform for Anova to coordinate the clinical trial process and bring all participants together, such as doctors, research organizations, and sponsors. The platform is a one-of-a-kind central hub that automates clinical trials by allowing potential new therapies to reach the market faster and at a lower cost for a larger number of people. Through standardization and automation, it also jumpstarts the development of new treatments.

Our partnership has already resulted in the first version of the Anova OneSource platform, which helps match medical research organizations with sponsors. The development process is ongoing as we implement additional functionality for biopharmaceutical companies, research physicians, and patients. The web platform met expectations and demonstrated truly strong performance. The actual numbers are amazing.

• More than 30,000 active studies have been conducted.

• More than 15,000 sponsors were attracted.

• More than 40,000 research carried out.

As you can see, the Anova project played a positive role in accelerating and improving the quality and organization of the clinical trial processes.